ArticleBMJ open diabetes research & care2026

Comparative safety of sulfonylurea therapies on cardiovascular and severe hypoglycemia outcomes among adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation.

Stacey Sklepinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.